⏳
Showing Q3 2025 data
Livelsberger Financial Advisory's Q4 2025 filing not yet available. Expected by Feb 14, 2026.
Livelsberger Financial Advisory
•CIK: 2015721•Filing: Q3 2025
**Livelsberger Financial Advisory** maintains a concentrated portfolio of six positions, currently managing $3M in assets. The strategy exhibits notable overweighting in the pharmaceutical and technology sectors, highlighted by the largest holding in ABBV at $1.1M. Further allocations include significant positions in AAPL ($0.4M) and ABT ($0.4M). The remaining capital is distributed across PH ($0.3M), MSFT ($0.2M), and XOM ($0.2M).
Total AUM
$2.7M
QoQ Performance
-48.0%
Positions
6
Top 10 Concentration
100.0%
Latest Filing
Q3 2025
Top Holdings Allocation
ABBV
AAPL
ABT
PH
MSFT
XOM
ABBV39.5%
AAPL16.5%
ABT16.3%
PH9.4%
MSFT9.3%
XOM9.0%
📈 Biggest Buys
📉 Biggest Sells
XOM
EXXON MOBIL CORP
-4.5%
9.0% of portfolio
Sector Breakdown
Healthcare55.8%
Technology25.7%
Other9.4%
Energy9.0%
🚪 Exited Positionssold since Q2 2025
+74 more exited positions
Changes from Q2 2025
↑4 increased
↓1 decreased
Historical Filings
Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023